It is noteworthy that in BRCA, pheochromocytoma and paraganglioma (PCPG), and SARC, patients in the CNN1 high-expression group had better OS than those in the CNN1 low-expression group (p < 0.05). The gene discussed is CNN1; the disease is hereditary pheochromocytoma-paraganglioma.